Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP931575.RAgtk_IEviR6Pupk8kFBMXA5pljl3Bh-NYC9wrOkTGZeU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP931575.RAgtk_IEviR6Pupk8kFBMXA5pljl3Bh-NYC9wrOkTGZeU130_assertion type Assertion NP931575.RAgtk_IEviR6Pupk8kFBMXA5pljl3Bh-NYC9wrOkTGZeU130_head.
- NP931575.RAgtk_IEviR6Pupk8kFBMXA5pljl3Bh-NYC9wrOkTGZeU130_assertion wasGeneratedBy ECO_0000203 NP931575.RAgtk_IEviR6Pupk8kFBMXA5pljl3Bh-NYC9wrOkTGZeU130_provenance.
- NP931575.RAgtk_IEviR6Pupk8kFBMXA5pljl3Bh-NYC9wrOkTGZeU130_assertion wasDerivedFrom befree-20140225 NP931575.RAgtk_IEviR6Pupk8kFBMXA5pljl3Bh-NYC9wrOkTGZeU130_provenance.
- NP931575.RAgtk_IEviR6Pupk8kFBMXA5pljl3Bh-NYC9wrOkTGZeU130_assertion SIO_000772 10397265 NP931575.RAgtk_IEviR6Pupk8kFBMXA5pljl3Bh-NYC9wrOkTGZeU130_provenance.
- NP931575.RAgtk_IEviR6Pupk8kFBMXA5pljl3Bh-NYC9wrOkTGZeU130_assertion evidence source_evidence_literature NP931575.RAgtk_IEviR6Pupk8kFBMXA5pljl3Bh-NYC9wrOkTGZeU130_provenance.
- NP931575.RAgtk_IEviR6Pupk8kFBMXA5pljl3Bh-NYC9wrOkTGZeU130_assertion description "[With rare exceptions, all five anti-PSMA mAbs reacted strongly with the neovasculature of a wide spectrum of malignant neoplasms: conventional (clear cell) renal carcinoma (11 of 11 cases), transitional cell carcinoma of the urinary bladder (6 of 6 cases), testicular embryonal carcinoma (1 of 1 case), colonic adenocarcinoma (5 of 5 cases), neuroendocrine carcinoma (5 of 5 cases), glioblastoma multiforme (1 of 1 cases), malignant melanoma (5 of 5 cases), pancreatic duct carcinoma (4 of 4 cases), non-small cell lung carcinoma (5 of 5 cases), soft tissue sarcoma (5 of 6 cases), breast carcinoma (5 of 6 cases), and prostatic adenocarcinoma (2 of 12 cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931575.RAgtk_IEviR6Pupk8kFBMXA5pljl3Bh-NYC9wrOkTGZeU130_provenance.